National Health Investors, Inc. (NHI) Income Statement

The 33.8% YoY revenue growth in 2026Q2 marks a significant acceleration from the 6.7% growth in 2025Q2, indicating a period of rapid portfolio expansion. This growth appears driven by both new investments and the transition of assets into SHOP structures, which inflate top-line revenue by recording gross resident fees. Investors should monitor whether this pace is sustainable, as it may be tied to one-time acquisitions rather than organic rent growth.

The dramatic decline in NOI margin from 96.8% to 31.1% between 2025Q2 and 2026Q1 appears directly tied to the strategic shift from triple-net leases to SHOP operations, where NHI now bears operating expenses. This transition reduces the high-margin rental income stream in favor of lower-margin, operationally intensive revenue. The 100% NOI margin in 2026Q2 is anomalous and likely reflects a data reporting quirk or one-time gain, warranting further investigation.

The 42.7% YoY FFO growth in 2026Q2, coupled with a 37% increase in FFO per share, suggests that the company is generating strong earnings growth without significant share dilution. This implies that management is funding expansion through debt or retained cash flow rather than ATM equity raises, which is favorable for existing shareholders. The dividend yield of 1.2% appears well-covered by FFO, though the low yield may reflect a high stock price rather than a weak payout.

The gap between net income and FFO of $25.5M in 2026Q2 represents the depreciation and amortization charges on NHI's real estate assets, which are non-cash and do not reflect economic depreciation. This distortion is typical for REITs but is particularly pronounced here, suggesting that the portfolio's assets are being depreciated aggressively. Investors should focus on FFO and AFFO as more accurate measures of cash-generating ability, especially given the company's shift toward SHOP operations where maintenance capex is higher.

The lack of same-store NOI disclosure in the provided data limits visibility into organic performance, but the revenue growth pattern suggests that expansion is acquisition-led. The SHOP portfolio's occupancy recovery, a key driver of organic growth, is not directly visible in the income statement data. Investors should monitor upcoming disclosures for same-store metrics to assess whether the portfolio's underlying properties are improving or merely growing through external investment.